headlines

ASU's Biodesign Institute and ImmuneRegen Collaborate to Investigate Possible Enhancement of Vaccine Against Norwalk Viruses
August 18, 2008

ImmuneRegen® BioSciences Confirms Homspera® Advances Wound Healing in Topical Application
August 13, 2008

IR BioSciences Holdings, Inc. Closes New $5 Million Funding Round
August 11, 2008

ImmuneRegen(R) BioSciences Advances Toward IND Filing
July 17, 2008

ImmuneRegen® BioSciences Confirms Adult Stem Cell Activity of Homspera® in Human Bone Marrow
June 9, 2008

 

 

 

 

 

 

We are excited to share with you that Immuneregen Biosciences has been nominated by the Vaccine Industry Excellence Awards as the Best Vaccine Start-up Company.

This nomination adds to all of the great progress we have been making as a company and reconfirms our impact in the industry.

more >>

 

PLEASE NOTE: Our ticker symbol changed to IRBS on August 1, 2008.

 

 

for job opportunities,
please contact
mlaroche@immuneregen.com